Gonorrhoea treatment failure caused by a Neisseria gonorrhoeae strain with combined ceftriaxone and high-level azithromycin resistance, England, February 2018

David W. Eyre*, Nicholas D. Sanderson, Emily Lord, Natasha Regisford-Reimmer, Kevin Chau, Leanne Barker, Markus Morgan, Robert Newnham, Daniel Golparian, Magnus Unemo, Derrick W. Crook, Tim E.A. Peto, Gwenda Hughes, Michelle Cole, Helen Fifer, Anne Edwards, Monique I. Andersson

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

272 Citations (Scopus)

Abstract

We describe a gonorrhoea case with combined high-level azithromycin resistance and ceftriaxone resistance. In February 2018, a heterosexual male was diagnosed with gonorrhoea in the United Kingdom following sexual intercourse with a locally resident female in Thailand and failed treatment with ceftriaxone plus doxycycline and subsequently spectinomycin. Resistance arose from two mechanisms combining for the first time in a genetic background similar to a commonly circulating strain. Urgent action is essential to prevent further spread.

Original languageEnglish
Article number1800323
JournalEurosurveillance
Volume23
Issue number27
DOIs
Publication statusPublished - 5 Jul 2018

Bibliographical note

Publisher Copyright:
© 2018, European Centre for Disease Prevention and Control (ECDC). All rights reserved.

Fingerprint

Dive into the research topics of 'Gonorrhoea treatment failure caused by a Neisseria gonorrhoeae strain with combined ceftriaxone and high-level azithromycin resistance, England, February 2018'. Together they form a unique fingerprint.

Cite this